John Rowley, MD
Plastic and Reconstructive Surgery · Phoenix, AZNPI 1285601112
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Sientra, Inc. at 35.4% of the total. Reporting peaked in 2021 at $119 and has fallen 78.8% since, to $25 in 2025. That places this record below the midpoint for plastic and reconstructive surgery clinicians in AZ, where the typical reported total is $2,637.
Across 14 payments — averaging $23.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sientra, Inc.$115
- Mentor Worldwide LLC$105
- Pacira Pharmaceuticals Incorporated$31
- Integra Lifesciences Corporation$27
- Sun Pharmaceutical Industries Inc.$25
- AbbVie$22
What the payments were for
- Food & beverage$326100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sientra, Inc. | 5 | $115 |
| Mentor Worldwide LLC | 4 | $105 |
| Pacira Pharmaceuticals Incorporated | 1 | $31 |
| Integra Lifesciences Corporation | 2 | $27 |
| Sun Pharmaceutical Industries Inc. | 1 | $25 |
| AbbVie | 1 | $22 |
How this compares
$326 in reported general payments places this provider in the 15th percentile of 63 plastic and reconstructive surgery providers in Arizona.
See all plastic and reconstructive surgery providers in Arizona →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 25 | $115 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $103 |
| Oxycodone Hcl | 25 | $79 |
| Clonidine Hcl | 16 | $6 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Phoenix
- Ha ChimPhoenix$355K
- Tamir MosharrafaPhoenix$160K
- Marc GottliebPhoenix$27K
- Randall CraftPhoenix$20K
- Jinesh ShahPhoenix$14K
- Martin BenjaminPhoenix$6K
- Ali MosharrafaPhoenix$5K
- Ashkaun ShaterianPhoenix$3K
- Jason MussmanPhoenix$2K
- Tim MatatovPhoenix$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.